These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21928410)

  • 61. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oncological and surgical outcome of total laryngectomy in combination with neck dissection in the elderly.
    Teymoortash A; Bohne F; Kissing L; Daniel H; Kurt B; Wilhelm T; Halmos GB; Hoch S
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1825-33. PubMed ID: 26972426
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cancer of the laryngopharynx.
    Ellis M
    J Laryngol Otol; 1968 May; 82(5):393-405. PubMed ID: 5655352
    [No Abstract]   [Full Text] [Related]  

  • 65. Bilateral versus ipsilateral neck dissection in oral and oropharyngeal cancer with contralateral cN0 neck.
    Knopf A; Jacob S; Bier H; Scherer EQ
    Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):3161-3168. PubMed ID: 32449025
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
    Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
    Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 68. The impact of bilateral neck dissection on pattern of recurrence and survival in supraglottic carcinoma.
    Weber PC; Johnson JT; Myers EN
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):703-6. PubMed ID: 8018320
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effectiveness of therapeutic selective neck dissection in laryngeal cancer.
    Allegra E; Franco T; Domanico R; La Boria A; Trapasso S; Garozzo A
    ORL J Otorhinolaryngol Relat Spec; 2014; 76(2):89-97. PubMed ID: 24777204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.
    Maquieira R; Haerle SK; Huber GF; Soltermann A; Haile SR; Stoeckli SJ; Broglie MA
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1841-8. PubMed ID: 26059208
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conservative neck dissection in oral cancer patients: a 5 year retrospective study in Malaysia.
    Balasundram S; Mustafa WM; Ip J; Adnan TH; Supramaniam P
    Asian Pac J Cancer Prev; 2012; 13(8):4045-50. PubMed ID: 23098514
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival.
    de Miguel-Luken MJ; Chaves-Conde M; Quintana B; Menoyo A; Tirado I; de Miguel-Luken V; Pachón J; Chinchón D; Suarez V; Carnero A
    Oncotarget; 2016 May; 7(22):31723-37. PubMed ID: 27166270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy.
    Soltys SG; Choi CY; Fee WE; Pinto HA; Le QT
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):994-9. PubMed ID: 22137026
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of elective neck dissection in patients undergoing salvage laryngectomy.
    Amit M; Hilly O; Leider-Trejo L; Popovtzer A; Gutfeld O; Shvero J; Fliss DM; Cohen JT; Bachar G; Gil Z
    Head Neck; 2013 Oct; 35(10):1392-6. PubMed ID: 23019150
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Early pharyngolaryngeal carcinomas with palpable nodes. French Head and Neck Study Group (GETTEC).
    Am J Surg; 1991 Oct; 162(4):377-80. PubMed ID: 1951892
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.
    Huang PW; Lin CY; Hsieh CH; Hsu CL; Fan KH; Huang SF; Liao CT; Ng SK; Yen TC; Chang JT; Wang HM
    Biomed J; 2018 Apr; 41(2):129-136. PubMed ID: 29866601
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
    Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.